Current NDC auxiliary source row compounder:3897

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 71170-910
Product Ndc: 71170-910
Product Ndc Digits: 71170910
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Fentanyl Citrate 50mcg/mL (2,500mcg Total Dose) 50mL IV Syringe
Proprietary Name Suffix: [empty]
Nonproprietary Name: Fentanyl Citrate 50mcg/mL (2,500mcg Total Dose) 50mL IV Syringe
Dosage Form Name: INJECTION, SOLUTION
Route Name: INTRAVENOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Apollo Care, LLC
Establishment Name: Apollo Care, LLC
Establishment Fei: [empty]
Substance Name: FENTANYL CITRATE
Active Ingredients Info: .05 mg/1 mL
History Active Ingredients Raw: FENTANYL CITRATE
History Active Ingredients Info Raw: .05 mg/1 mL
History Dosage Raw: INJECTION, SOLUTION
Dea Schedule: CII
Package Ndc Raw: 71170-910-25
Package Ndc: 71170-910-25
Package Ndc Digits: 7117091025
Package Ndc11: 71170091025
Package Description: 50 mL in 1 SYRINGE (71170-910-25)
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:3897
Source Row Number: 3897
Source Row Hash: a98e8cca326404eaeb408bb6d927048aa4a099a658eb8f252a0a30eb10caeb79
Import Run Id: 20261025T224840Z
Loaded At: 2026-10-25 22:53:27

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "71170-910",
    "DEASCHEDULE": "CII",
    "LABELERNAME": "Apollo Care, LLC",
    "SUBSTANCENAME": "FENTANYL CITRATE",
    "DOSAGEFORMNAME": "INJECTION, SOLUTION",
    "NDCPACKAGECODE": "71170-910-25",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Fentanyl Citrate 50mcg/mL (2,500mcg Total Dose) 50mL IV Syringe",
    "REPORTINGPERIOD": "2025-1",
    "NONPROPRIETARYNAME": "Fentanyl Citrate 50mcg/mL (2,500mcg Total Dose) 50mL IV Syringe",
    "PACKAGEDESCRIPTION": "50 mL in 1 SYRINGE (71170-910-25) ",
    "ACTIVEINGREDIENTSINFO": ".05 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:3897
Source Row Number: 3897
Status Scope: package
Lookup Ndc: 71170-910-25
Lookup Ndc Digits: 7117091025
Product Ndc: 71170-910
Product Ndc Digits: 71170910
Package Ndc: 71170-910-25
Package Ndc Digits: 7117091025
Package Ndc11: 71170091025
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: a98e8cca326404eaeb408bb6d927048aa4a099a658eb8f252a0a30eb10caeb79
Import Run Id: 20261025T224840Z
Loaded At: 2026-10-25 22:53:27